Literature DB >> 11286983

p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.

V P Torchilin1, T S Levchenko, A N Lukyanov, B A Khaw, A L Klibanov, R Rammohan, G P Samokhin, K R Whiteman.   

Abstract

We have attempted to simplify the procedure for coupling various ligands to distal ends of liposome-grafted polyethylene glycol (PEG) chains and to make it applicable for single-step binding of a large variety of a primary amino group-containing substances, including proteins and small molecules. With this in mind, we have introduced a new amphiphilic PEG derivative, p-nitrophenylcarbonyl-PEG-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (pNP-PEG-DOPE), synthesized by reaction of DOPE with excess of bis(p-nitrophenylcarbonyl)-PEG in a chloroform/triethylamine mixture. pNP-PEG-DOPE readily incorporates into liposomes via its PE residue, and easily binds primary amino group-containing ligands via its water-exposed pNP groups, forming stable and non-toxic urethane (carbamate) bonds. The reaction between the pNP group and the ligand amino group proceeds easily and quantitatively at pH around 8.0, and remaining free pNP groups are promptly eliminated by spontaneous hydrolysis. Therefore, pNP-PEG-DOPE could serve as a very convenient tool for protein attachment to the distal ends of liposome-grafted PEG chains. To investigate the applicability of the suggested protocol for the preparation of long-circulating targeted liposomes, we have coupled several proteins, such as concanavalin A (ConA), wheat germ agglutinin (WGA), avidin, monoclonal antimyosin antibody 2G4 (mon2G4), and monoclonal antinucleosome antibody 2C5 (mon2C5) to PEG-liposomes via terminal pNP groups and studied whether the specific activity of these immobilized proteins is preserved. The method permits the binding of several dozens protein molecules per single 200 nm liposome. All bound proteins completely preserve their specific activity. Lectin-liposomes are agglutinated by the appropriate polyvalent substrates (mannan for ConA-liposomes and glycophorin for WGA-liposomes); avidin-liposomes specifically bind with biotin-agarose; antibody-liposomes demonstrate high specific binding to the substrate monolayer both in the direct binding assay and in ELISA. A comparison of the suggested method with the method of direct membrane incorporation was made. The effect of the concentration of liposome-grafted PEG on the preservation of specific protein activity in different coupling protocols was also investigated. It was also shown that pNP-PEG-DOPE-liposomes with and without attached ligands demonstrate increased stability in mouse serum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286983     DOI: 10.1016/s0005-2728(01)00165-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  66 in total

1.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.

Authors:  V P Torchilin; R Rammohan; V Weissig; T S Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 2.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

3.  Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro.

Authors:  Aruna Roby; Suna Erdogan; Vladimir P Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2005-12-02       Impact factor: 5.571

4.  Receptor-specific targeting with liposomes in vitro based on sterol-PEG(1300) anchors.

Authors:  Markus Gantert; Felicitas Lewrick; Joanna E Adrian; Jochen Rössler; Thomas Steenpass; Rolf Schubert; Regine Peschka-Süss
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

Review 5.  Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation.

Authors:  Portonovo S Ayyaswamy; Vladimir Muzykantov; David M Eckmann; Ravi Radhakrishnan
Journal:  J Nanotechnol Eng Med       Date:  2013-07-11

6.  Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.

Authors:  Bhushan S Pattni; Srikar G Nagelli; Bhawani Aryasomayajula; Pranali P Deshpande; Abhijit Kulkarni; William C Hartner; Ganesh Thakur; Alexei Degterev; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2016-06-28       Impact factor: 4.200

7.  Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.

Authors:  Anita Schnyder; Stefan Krähenbühl; Michael Török; Jürgen Drewe; Jörg Huwyler
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

8.  Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.

Authors:  Abraham H Abouzeid; Niravkumar R Patel; Can Sarisozen; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2014-02-13       Impact factor: 4.200

9.  Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.

Authors:  Robert Riehle; Bhushan Pattni; Aditi Jhaveri; Abhijit Kulkarni; Ganesh Thakur; Alexei Degterev; Vladimir Torchilin
Journal:  Pharm Res       Date:  2016-03-07       Impact factor: 4.200

10.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.

Authors:  Vladimir P Torchilin; Tatyana S Levchenko; Ram Rammohan; Natalia Volodina; Brigitte Papahadjopoulos-Sternberg; Gerard G M D'Souza
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.